Drug intelligence / Profile preview

dienogest + micronized progesterone

Development stage
Preclinical
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral
01

Overview

Dienogest + micronized progesterone is a combination drug consisting of two different synthetic and natural progestogens. **Dienogest** is a synthetic progestin with high specificity for the progesterone receptor, antiandrogenic properties, and is used primarily for endometriosis and as a component of contraceptives. Its mechanism includes ovulation inhibition, endometrial atrophy, and suppression of estradiol production, leading to the regression of endometriotic tissue. **Micronized progesterone** is a natural form of progesterone processed to improve oral bioavailability, used for hormone replacement therapy, endometrial protection, and treatment of menstrual disorders. This combination, though not a standard or well-established marketed formulation per current available literature, would conceptually provide both potent endometrial effects (from dienogest) and systemic progestogenic support (from micronized progesterone), possibly for the treatment of endometriosis or hormone therapy settings. No specific brand or product is identified or widely marketed as this exact combination.

02

Targets

PR (Progesterone receptor)AR (Adrenergic receptors)

Beyond the preview

Go deeper on dienogest + micronized progesterone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dienogest + micronized progesterone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call